Yi Qingqing 4
4 · BeiGene, Ltd. · Filed Jun 11, 2019
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Share Option (Right to Buy)
2019-06-05+64,610→ 64,610 totalExercise: $9.23Exp: 2029-06-04→ Ordinary Shares (64,610 underlying)
Footnotes (2)
- [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares.
- [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.